Board summary
Key figures
31,650
Registered population
54.3% aged 18–64
28.7%
Aged 65+
ICB 21.9% · England 17.9%
4.6%
Ethnic minority (non-White)
1.8% Asian · England 9.6%
5.6%
In IMD quintile 1
ICB 9.2% · England 21.0%
~1,646
Core20 residents (est.)
Resident basis; registered basis ~1,804 · see page 3
6,429
Hypertension register
+5.16% in 3 yrs · England +5.60%
341
SMI register
17.1% of Arun's
762
COPD register
Reviews +4.42% in 3 yrs
Forecast to 2030
7,274
Hypertension patients, 2030
+845 on today
72.0%
QRISK ≥20% on statins, 2030
+3.47pp over 3 yrs
6.4%
Cancer prevalence, 2030
England 4.5%
Three things the board should see
Deprivation and vaccination gaps at Bersted Green Surgery.
Bersted Green Surgery holds all 1,804 estimated Core20 patients (14.3% share) and 33.0% QOF vaccination achievement, against 82.9% at Avisford Medical Group.
Asthma reviews and learning disability register lag England.
Asthma reviews changed by -4.0% over 2023 to 2025 (England +4.4%), leaving about 730 patients unreviewed, while learning disability prevalence is 0.5% (Arun 0.8%).
Hypertension blood pressure control exceeds comparator benchmarks.
Blood pressure control is 72.6% under age 80 (England 67.8%, Arun 65.6%) and 82.3% at age 80+ (England 81.2%), though secondary statin therapy is.
Population, age and ethnicity
Patients aged 65+ comprise 28.7% of the list, alongside 52 catchment care homes
Regis Healthcare PCN serves 31,650 registered patients across three practices. Patients aged 65+ comprise 28.7% (9,092 patients), below Arun (29.2%) but above NHS Sussex Integrated Care Board (21.9%) and England (17.9%). Those aged 18–64 make up 54.3% (Arun 54.9%, ICB 60.5%, England 62.7%), and children aged 0–17 represent 16.9% (Arun 15.9%, ICB 17.7%, England 19.6%). Derived from Census usual residents rather than GP registers, 95.4% are White (Arun 95.8%, ICB 91.0%, England 81.1%), leaving a 4.6% non-White share. Projected list growth to 2030 is 1.8% (Arun 2.7%, ICB 2.1%, England 2.3%), using an unverified method.
Age profile
65+: ICB 21.9%, England 17.9%
Ethnicity
Older people · falls rows are Arun local-authority (LA) data, not PCN
| Measure | Local | South East | England | Period |
|---|---|---|---|---|
| Falls admissions, 65+, per 100,000 (Arun LA) | 2,327 | 2,018 | 1,958 | 2024/25 |
| Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN) | 79.3% | 82.2% | 81.9% | 2024/25 |
| Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN) | 63.8% | 57.8% | 57.4% | 2024/25 |
| Falls admissions, 65 to 79, per 100,000 (Arun LA) | 1,216 | 981 | 955 | 2024/25 |
| Falls deaths, all ages, per 100,000 (Arun LA) | 13.3 | 14.0 | 14.8 | 2022‑24 |
Deprivation and Core20
Core20 deprivation is 5.6% overall and concentrated entirely at Bersted Green Surgery
Registered Core20 prevalence (patients living in the most deprived 20% of areas in England, IMD deciles 1 and 2) is 5.6%, below England (21.0%), Arun (9.8%) and NHS Sussex Integrated Care Board (9.2%). Weighted practice share is 5.7%, reflecting a 0.13 percentage point reconciliation difference. Core20 is concentrated entirely at Bersted Green Surgery (14.3%, an estimated 1,804 patients), with Arundel Surgery and Avisford Medical Group at 0.0%. A resident-based estimate finds 1,646 people. Targeted inequality resources should focus on Bersted Green Surgery rather than PCN-wide distribution.
% of patients in IMD quintile 1, by practice
Dashed line: England 21.0% · right column: Core20 patients, registered basis
PLUS groups and inclusion health
PLUS groups and inclusion health
341
SMI register
1.07% recorded prevalence
167
Learning disability register
0.53% recorded prevalence
52
Care homes, 1,581 beds
In the PCN catchment
8.9%
Provide unpaid care
Arun, Census 2021
Learning disability prevalence is 0.5% (167 patients; Arun 0.8%, ICB 0.6%, England 0.6%), and severe mental illness is 1.1% (341 patients; Arun 1.1%, ICB 1.1%, England 1.0%). Catchment care homes total 52 (1,581 beds). Arun context includes about 2,800 unpaid carers and 16 rough sleepers. Lower recorded learning disability prevalence against comparators does not establish under-detection or unmet need, but could warrant clinical record review.
Severe mental illness: physical health checks
Across 341 severe mental illness patients, BMI recording is 78.8% (England 82.1%) and alcohol recording is 78.5% (England 81.8%), while blood pressure checks reach 83.6% (England 83.4%). Lower recording may leave metabolic risks unmonitored.
Clinical focus: hypertension and lipids
Clinical focus: hypertension and lipids
6,429
Hypertension register
+5.16%
Register growth, 3 yrs
Arun +4.55% · England +5.60%
+5.37pp
BP control, under 80
≤140/90 · +0.93pp aged 80+
+845
More patients by 2030
Forecast 7,274 (22.41%)
Hypertension case-finding and control
Hypertension register prevalence is 20.3% (6,429 patients), above Arun (19.8%), NHS Sussex Integrated Care Board (16.3%) and England (15.2%). Blood pressure monitoring reached 92.3% (England 90.0%), and patients treated to target reached 74.4% (England 70.3%). Blood pressure control is 72.6% in patients aged under 80 (England 67.8%) and 82.3% in patients aged 80 and over (England 81.2%), though Arundel Surgery achieved 78.0% in the 80 and over cohort. Hypertension control exceeds England overall, but lower control in patients aged 80 and over at Arundel Surgery highlights an opportunity to prioritise older-adult recall.
Lipids and statins
QRISK ≥ 20% lipid therapy is 64.5% (England 63.6%). However, secondary prevention statin treatment in diabetes with CVD history is 80.6% (England 84.4%) and lipid therapy in CKD is 68.6% (England 70.3%). Secondary prevention lipid coverage trails England, indicating that high-risk diabetic and CKD patients require prioritised treatment review.
| Measure | Items | Cost / item | ICB | England | Annual spend |
|---|---|---|---|---|---|
| Lipid-modifying, 2026 | 70,360 | £3.00 | £2.42 | £1.86 | £211,080 |
| Cardiovascular (all), 2025 | 91,905 | £3.23 | £3.32 | £3.33 | £296,853 |
In 2026, lipid-modifying drugs cost £3.00 per item across 70,360 items (Arun £2.81, NHS Sussex Integrated Care Board £2.42, England £1.86), spending £80,210 more than at England's unit cost. Unit cost is higher than England and ICB benchmarks, pointing to an opportunity to review lipid-modifying prescribing choices.
Clinical focus: respiratory, cancer register and children
Clinical focus: respiratory, cancer register and children
Respiratory
−4.04%
Asthma reviews, PCN 3-yr % change
+4.44%
Asthma reviews, England 3-yr % change
+3.08%
Asthma prevalence, PCN 3-yr % change
COPD annual reviews reach 85.6% (England 76.4%, Arun 74.5%) across 762 registered patients. Conversely, 12-month asthma reviews fell 4.0% over 2023 to 2025 (England +4.4%), with current PCN coverage at 67.2% across 2,222 patients, leaving about 730 unreviewed. At Bersted Green Surgery, asthma review coverage is 59.7%. Paediatric asthma prescribing stands at 1,966 items per 1,000 aged 5-19 (England 1,488 rate), while second-hand smoke recording is 76.5% (England 78.8%). Falling asthma reviews may leave exacerbation risks unmonitored despite high prescribing volumes.
Cancer register and children's immunisation
Cancer prevalence is 5.4% (1,710 patients; England 3.8%). In childhood immunisation, age-5 MMR1 is 92.6% (England 91.7%), while MMR2 is 80.9% (England 82.8%, NHS Sussex ICB 87.1%), showing an 11.7 pp dose difference (18.4 pp at Bersted Green Surgery). MMR1 at 24 months is 83.0% (England 88.3%). Lower second-dose uptake may leave children incompletely protected before school entry.
Dashed line: 95% national coverage target · solid tick: England
Early cancer diagnosis
Early cancer diagnosis
58.5%
Sussex ICB, stage 1–2
55.3%
England, 2022
75%
National ambition by 2028
~1,360
Extra early-stage cases a year to reach the ambition
| Stage 1–2 share by cancer type, 2022 | Sussex ICB | England | No usable stage | Staged cancers |
|---|---|---|---|---|
| Prostate | 56.6% | 53.2% | 19% | 1,668 |
| Breast | 86.1% | 85.4% | 23% | 1,400 |
| Bowel | 49.8% | 47.0% | 26% | 1,133 |
| Lung | 30.3% | 33.8% | 15% | 1,058 |
| Skin cancer | 95.3% | 87.8% | 17% | 698 |
In 2022, across NHS Sussex ICB, 58.5% of cancers with a known stage (4,799 of 8,209) were diagnosed at stage 1 or 2, above England (55.3%) but 16.5 pp below the 75.0% national ambition by 2028 (about 1,360 extra cases needed). Known stage was recorded for 64.3% of registered cancers (8,209 of 12,766; England 67.0%). This reflects system performance, not PCN delivery. Locally, PCN cervical screening coverage is 69.2% (England 66.8%) but is 58.2% at Bersted Green Surgery, while breast screening coverage is 69.5% (England 69.9%). Primary care screening gaps at lower-uptake practices may delay early cancer detection across the wider system.
Cancer waits, diagnostics and community services
Cancer waits, diagnostics and community services
Cancer waits and diagnostics, Jul 2026 (provisional)
In Jul 2026 (provisional), University Hospitals Sussex NHS Foundation Trust met the 62-day referral to treatment standard in 65.2% of pathways, 19.8 pp below the 85.0% standard, trailing NHS Surrey and Sussex Integrated Care Board (71.5%), England (71.2%), Portsmouth Hospitals University NHS Trust (75.2%) and Royal Surrey NHS Foundation Trust (84.5%). The 28-day faster diagnosis rate was 74.0% (standard 75.0%, England 79.3%). For diagnostics, 12.9% waited 6+ weeks across all tests (England 23.1%), though colonoscopy waits reached 39.3% (England 30.8%). Acute pathway bottlenecks may extend treatment intervals for referred PCN patients.
| Pathways within standard (%) | Sussex | Portsmouth | Royal Surrey | Surrey and Sussex ICB | England |
|---|---|---|---|---|---|
| 28-day faster diagnosis (75%) | 74.01 | 66.81 | 82.62 | 79.29 | 79.32 |
| 31-day treatment (96%) | 76.79 | 94.78 | 96.43 | 90.45 | 92.50 |
| 62-day referral to treatment (85%) | 65.20 | 75.20 | 84.48 | 71.51 | 71.16 |
| Diagnostic waits over 6 weeks (%) | Sussex | Portsmouth | Royal Surrey | England |
|---|---|---|---|---|
| MRI | 5.62 | 50.36 | 0.00 | 21.40 |
| CT | 8.57 | 13.06 | 0.15 | 9.92 |
| Echocardiography | 0.39 | 32.75 | 1.55 | 28.48 |
| Colonoscopy | 39.35 | 82.52 | 0.00 | 30.83 |
| Gastroscopy | 20.02 | 74.88 | 0.00 | 29.02 |
| All 15 DM01 tests | 12.95 | 51.96 | 8.82 | 23.14 |
| Community services activity | West Sussex residents | Surrey and Sussex ICB |
|---|---|---|
| Care contacts | 78,050 | 309,615 |
| Referrals | 16,015 | 66,930 |
| Patients with a contact | 19,770 | 85,660 |
Community services (residents of West Sussex), Jun 2026 (provisional). In Jun 2026 (provisional), experimental community data recorded 78,050 care contacts across 19,770 West Sussex residents, with adults aged 65+ accounting for 72.7% of contacts. Across NHS Surrey and Sussex Integrated Care Board, 309,615 contacts were recorded across 85,660 patients. High community contact volume among older residents underscores demand for joined-up post-diagnosis care.
Practice variation and patient experience
Practice variation is sharp across clinical vaccination achievement and patient-reported telephone access
Across the 2025/26 Quality and Outcomes Framework, clinical domain achievement is consistently high across all three practices (99.8% to 100.0%). However, vaccination and immunisation achievement reveals a 49.9 pp range, from 33.0% at Bersted Green Surgery (22.1 pp below England's 55.2%) to 82.9% at Avisford Medical Group, while personalised care adjustment rates remain between 1.6% and 4.0%.
GP Patient Survey by practice
| Practice | Responses | % in IMD Q1 | Phone easy | Request led to appt | Overall good |
|---|---|---|---|---|---|
| Arundel Surgery | 114 | 0.0 | 77.3% | 75.1% | 89.1% |
| Avisford Medical | 122 | 0.0 | 41.5% | 79.5% | 73.8% |
| Bersted Green | 98 | 14.3 | 46.2% | 75.4% | 71.4% |
| England | — | ~21 | 56.9% | 71.6% | 76.7% |
Where the PCN lags
Sixteen of 25 three-year trends trail England, led by falling asthma reviews
Across 25 tracked measures, 16 three-year changes trail England. The widest relative lag is annual asthma reviews, which fell 4.0% while England rose +4.4% (an 8.48-point gap). Absolute delivery shortfalls include psychosis alcohol recording (+1.3 pp vs England +5.4 pp) and smoking cessation offers, which fell 2.7 pp (England +0.1 pp). Conversely, relative strengths include under-80 blood pressure control (+8.0% vs England +3.2%), cervical screening (+2.1% vs England -1.0%), and hypertension treated to target (+6.4% vs England +3.6%). Slower review and recording gains may indicate where recall protocols warrant clinical audit.
3-year change · PCN vs England
Bars show the direction and scale of relative change. Orange: PCN · Grey: England.
Asthma reviews
Alcohol record (psychosis)
Learning disability register
Dementia register
Smoking support (SMI)
BP control, under 80
Cervical screening
Hypertension treated to target
What the data can't tell us: gaps and local assets
What the data can't tell us: gaps and local assets
| Local assets and voluntary sector | PCN | Arun | Asset | PCN | Arun |
|---|---|---|---|---|---|
| Care homes (catchment) | 52 (1,581 beds) | n/a | Schools (catchment) | 48 | n/a |
| Children's centres | 4 | 7 | Places of worship | 46 | 68 |
| Libraries | 2 | 7 | Homelessness support (VCS) | 0 | no data |
| Day centres (VCS) | n/a | 1 | Carers support groups (VCS) | n/a | 1 |
| Primary schools (LA maintained) | 17 | 21 | Primary academies | 9 | 19 |
| Special schools | n/a | 1 |
0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.
Options for the PCN
Options for the PCN
Each option in full
Option 1
Asthma annual review recall and templates
Asthma reviews in the last 12 months fell 4.0% over 2023 to 2025 (England +4.4%); at 67.2% coverage across 2,222 patients (59.7% at Bersted Green Surgery), about 730 lack a recorded review. Moderate effort to run.
Evidence base: the annual asthma review is the process gap between the register and outcomes.
Policy anchor: Core20PLUS5 chronic respiratory disease priority.
Option 2
Learning disability register validation and audit
Recorded learning disability prevalence is 0.5% (167 patients) against 0.6% in England and 0.8% in Arun (+1.9% change over 2023 to 2025 vs England +5.4%), a modelled gap of +19 to +76 patients. Low cost, quick to run.
Evidence base: the register is the cohort for the annual health check and LeDeR learning; people with a learning disability die on average 20 years earlier and are a Core20PLUS5 PLUS group.
Policy anchor: annual health checks for 75% of people aged 14+ on the register (Network Contract DES); Oliver McGowan mandatory training.
Option 3
Complete physical checks on SMI register
Across 341 SMI patients (1.1% prevalence), 12-month BMI recording is 78.8% (England 82.1%) and alcohol recording is 78.5% (England 81.8%, +1.3 pp change over 2023 to 2025 vs England +5.4 pp). Low cost, quick to run.
Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.
Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.
Provenance and audit trail
Provenance and audit trail
Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.
| Recommendation | Indicator(s) | Policy anchor | Data level |
|---|---|---|---|
| Targeted Core20 outreach and reconciliation (p3) | Core20 cohort (IMD quintile 1) | Core20PLUS5 · 10YHP equity test | PCN |
| SMI metabolic check recall (p4) | SMI register with a BMI recorded in the last 12 months | MHIS · From Harm to Hope | PCN |
| Older adult blood pressure review (p5) | Last BP reading of patients (80+ yrs with hypertension) in the last 12 months is <= 150/90 mmHg (denominator incl. PCAs) | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN |
| Preschool MMR second dose recall (p6) | MMR dose 2 coverage at age 5 | 10YHP sickness to prevention · 95% target | PCN |
| Cervical screening outreach (p7) | Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs) | Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026 | PCN |
| Practice telephone triage review (p9) | GPPS last request led to a booked appointment · GPPS good overall experience of the practice | 10YHP, hospital to community | Practice |
| Option 1 · Asthma annual review recall and templates (p12) | Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) | Core20PLUS5 respiratory | PCN & Practice |
| Option 2 · Learning disability register validation and audit (p12) | Learning disability register · Learning disability: QOF prevalence | 75% annual health checks (Network Contract DES) · Oliver McGowan | PCN |
| Option 3 · Complete physical checks on SMI register (p12) | Severe mental illness register · Severe mental illness: QOF prevalence · SMI register with a BMI recorded in the last 12 months | MHIS · From Harm to Hope | PCN |
Data sources
Data sources
Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.
| Dataset | Level | Period | Used for |
|---|---|---|---|
| Coplug indicator tables: census, deprivation and QOF measures | PCN & Practice | 2023 to 2025, projected to 2030; 2023 to 2024 | Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12 |
| MHCLG, Rough sleeping snapshot in England: autumn 2025 | Local authority | Autumn 2025 | Pages 2, 4 |
| OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) | PCN | 2024/25 | Pages 2, 4 |
| OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002) | Local authority | 2024/25; 2022-24 | Pages 2, 4 |
| ONS, Census 2021 TS039: provision of unpaid care (age-standardised) | Local authority | Census 2021 | Pages 2, 4 |
| QOF registers, prevalence and care processes (Coplug indicator tables) | Practice | 2023 to 2025, projected to 2030 | Pages 4, 5, 6, 7, 8, 10 |
| UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26 | PCN & Practice | Q1 2025/26 | Pages 4, 6 |
| UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026 | ICB | 2025/26 season to 28 Feb 2026 | Pages 4, 6 |
| NHS England, Cancer Waiting Times: July 2026 monthly time series with revisions | ICB & Provider | Jul 2026 (provisional) | Pages 7, 8 |
| NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental data | ICB & Local authority | Jun 2026 (provisional) | Pages 7, 8 |
| NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026 | Provider | Jul 2026 | Pages 7, 8 |
| National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022 | ICB | 2022 | Pages 7, 8 |
| NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted) | Practice | Survey Jan-Apr 2026 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domain | Practice | 2025/26 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domain | Practice | 2025/26 | Page 9 |
| Coplug indicator catalogue — definitions, cohorts, policy anchors | Reference | Current | Evidence-base lines, page 13 |
Methods, data-quality notes and limitations
Methods, data-quality notes and limitations
Methods
Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.
Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.
Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.
Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.
